Sign in
8-K

Current Report

Fulcrum Therapeutics, Inc. Filed Acc 0001193125-21-188915

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading d163356d8k.htm…